Medical Packaging Company (EGX:MEPA)
Egypt · Delayed Price · Currency is EGP 1.300
+0.030 (2.36%)
At close: Oct 2, 2025
Medical Packaging Company Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 133.79 | 130.92 | 91.02 | 59.24 | 47.01 | 36.73 | Upgrade | |
Revenue Growth (YoY) | 1.09% | 43.83% | 53.64% | 26.03% | 27.97% | 23.42% | Upgrade |
Cost of Revenue | 83.23 | 78.77 | 47.42 | 39.22 | 33.17 | 27.68 | Upgrade |
Gross Profit | 50.56 | 52.15 | 43.6 | 20.02 | 13.84 | 9.05 | Upgrade |
Selling, General & Admin | 14.26 | 10.8 | 8.17 | 4.47 | 4.84 | 4.28 | Upgrade |
Operating Expenses | 18.08 | 19.49 | 8.17 | 4.47 | 4.84 | 4.31 | Upgrade |
Operating Income | 32.48 | 32.66 | 35.43 | 15.56 | 9 | 4.74 | Upgrade |
Interest Expense | -0.59 | - | - | -0.87 | -0.37 | - | Upgrade |
Interest & Investment Income | 15.12 | 11.49 | 8.95 | 0.76 | - | - | Upgrade |
Currency Exchange Gain (Loss) | 0.04 | -2.77 | -17.56 | -0.24 | 0.02 | -0.04 | Upgrade |
Other Non Operating Income (Expenses) | 3.15 | 0.43 | -0.68 | 3.02 | -0.31 | -0.39 | Upgrade |
EBT Excluding Unusual Items | 50.19 | 41.8 | 26.13 | 18.22 | 8.34 | 4.31 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 0.03 | - | - | Upgrade |
Other Unusual Items | - | 8.66 | - | - | - | - | Upgrade |
Pretax Income | 50.19 | 50.46 | 26.13 | 18.25 | 8.34 | 4.31 | Upgrade |
Income Tax Expense | 13.21 | 13.88 | 5.03 | 12.51 | 0.66 | -0.1 | Upgrade |
Net Income | 36.98 | 36.58 | 21.1 | 5.74 | 7.68 | 4.41 | Upgrade |
Net Income to Common | 36.98 | 36.58 | 21.1 | 5.74 | 7.68 | 4.41 | Upgrade |
Net Income Growth | -11.24% | 73.33% | 267.78% | -25.27% | 74.25% | -20.60% | Upgrade |
Shares Outstanding (Basic) | 655 | 655 | 655 | 345 | 345 | 345 | Upgrade |
Shares Outstanding (Diluted) | 655 | 655 | 655 | 345 | 345 | 345 | Upgrade |
Shares Change (YoY) | - | - | 89.85% | - | - | 7.81% | Upgrade |
EPS (Basic) | 0.06 | 0.06 | 0.03 | 0.02 | 0.02 | 0.01 | Upgrade |
EPS (Diluted) | 0.06 | 0.06 | 0.03 | 0.02 | 0.02 | 0.01 | Upgrade |
EPS Growth | -11.24% | 73.33% | 93.72% | -25.27% | 74.25% | -26.36% | Upgrade |
Free Cash Flow | 14.56 | 8.35 | 6.61 | 23.46 | 10.01 | 2.07 | Upgrade |
Free Cash Flow Per Share | 0.02 | 0.01 | 0.01 | 0.07 | 0.03 | 0.01 | Upgrade |
Gross Margin | 37.79% | 39.83% | 47.90% | 33.80% | 29.44% | 24.64% | Upgrade |
Operating Margin | 24.27% | 24.94% | 38.92% | 26.26% | 19.14% | 12.91% | Upgrade |
Profit Margin | 27.64% | 27.94% | 23.18% | 9.69% | 16.33% | 12.00% | Upgrade |
Free Cash Flow Margin | 10.88% | 6.38% | 7.26% | 39.60% | 21.29% | 5.64% | Upgrade |
EBITDA | 38.29 | 37.82 | 40.49 | 19.85 | 12.67 | 8.09 | Upgrade |
EBITDA Margin | 28.62% | 28.89% | 44.49% | 33.51% | 26.96% | 22.03% | Upgrade |
D&A For EBITDA | 5.81 | 5.17 | 5.07 | 4.3 | 3.68 | 3.35 | Upgrade |
EBIT | 32.48 | 32.66 | 35.43 | 15.56 | 9 | 4.74 | Upgrade |
EBIT Margin | 24.27% | 24.94% | 38.92% | 26.26% | 19.14% | 12.91% | Upgrade |
Effective Tax Rate | 26.32% | 27.51% | 19.25% | 68.56% | 7.90% | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.